Financial results - PHARMA PARTNERS SRL

Financial Summary - Pharma Partners Srl
Unique identification code: 33836631
Registration number: J2023003746405
Nace: 4646
Sales - Ron
3.735.236
Net Profit - Ron
511.479
Employees
8
Open Account
Company Pharma Partners Srl with Fiscal Code 33836631 recorded a turnover of 2024 of 3.735.236, with a net profit of 511.479 and having an average number of employees of 8. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Pharma Partners Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 0 11.465 177.664 848.923 828.593 391.597 434.649 201.428 1.660.334 3.735.236
Total Income - EUR 0 11.465 177.664 848.923 828.769 392.046 435.196 202.132 1.677.071 3.758.786
Total Expenses - EUR 29.304 43.980 198.279 837.927 797.762 335.412 376.922 188.900 1.550.567 3.181.897
Gross Profit/Loss - EUR -29.304 -32.516 -20.614 10.997 31.007 56.635 58.274 13.231 126.504 576.889
Net Profit/Loss - EUR -29.304 -32.630 -28.259 2.475 22.721 52.972 54.002 11.418 107.042 511.479
Employees 1 2 2 2 2 3 3 2 8 8
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 126.2%, from 1.660.334 euro in the year 2023, to 3.735.236 euro in 2024. The Net Profit increased by 405.035 euro, from 107.042 euro in 2023, to 511.479 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Pharma Partners Srl

Rating financiar

Financial Rating -
PHARMA PARTNERS SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Pharma Partners Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharma Partners Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharma Partners Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharma Partners Srl - CUI 33836631

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 0 0 0 21.720 26.117 24.765 23.805 3.112 177.241 145.449
Current Assets 12.233 13.432 53.112 109.815 91.659 110.613 170.776 57.176 1.251.007 2.068.334
Inventories 0 0 15.634 0 11.274 0 0 0 28.406 16.221
Receivables 624 2.143 4.652 83.426 77.129 88.509 149.096 2.732 1.126.515 2.020.454
Cash 11.609 11.289 32.826 26.390 3.256 22.104 21.680 54.444 96.087 31.659
Shareholders Funds -28.107 -60.451 -87.688 -83.603 -59.263 -5.168 48.949 14.054 109.872 515.017
Social Capital 2.250 2.227 2.189 2.149 2.107 2.067 2.022 2.028 2.022 2.010
Debts 40.340 73.883 140.800 215.138 177.680 141.107 146.000 46.945 1.318.376 1.699.326
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 2.068.334 euro in 2024 which includes Inventories of 16.221 euro, Receivables of 2.020.454 euro and cash availability of 31.659 euro.
The company's Equity was valued at 515.017 euro, while total Liabilities amounted to 1.699.326 euro. Equity increased by 405.759 euro, from 109.872 euro in 2023, to 515.017 in 2024.

Risk Reports Prices

Reviews - Pharma Partners Srl

Comments - Pharma Partners Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.